Life Sciences

Our Industry
Coverage

With one of the largest life sciences practices in the U.S., Wilson Sonsini’s industry legacy dates to the formative years of biotech and medical device. Working closely with scientists and entrepreneurs who grew their companies into thriving businesses, we have worked alongside to support their endeavors from whiteboard to clinical trial and beyond.

Industry Highlights

Celebrating our
founders’ successes

Life Sciences Industry

2013

NanoString Files IPO Worth $54 Million

Molecular Diagnostics

2020

Lumos Pharma Sets Sights on SPAC

Drug Discovery

2020

Oric Pharmaceuticals IPO Raises $120 Million

Drug Discovery

2020

Applied Molecular Transport Closes IPO at $154 Million

Pharmaceuticals

2020

ALX Oncology Prices IPO at $161 Million

Immuno-Oncology

2020

HintMD is Acquired by Revance Therapeutics

Mobile Healthcare Platform

2020

Athira Pharma Closes $204 Million IPO

Drug Discovery

2020

PMV Pharmaceuticals Joins Nasdaq with $211 Million IPO

Drug Discovery

2020

Artelo Biosciences Announces $6.6 Million Public Offering

Cannabinoid-Based Therapies

2020

Seer IPO Raises $175 Million in Nasdaq Debut

Decision / Risk Analysis

Attorneys

focused
on this
industry

See all ECP attorneys

Josh
Beser

Martin

Martin

Martin
Waters

Jennifer

Jennifer

Jennifer
Fang

Megan

Megan

Megan
Baier

Craig

Craig

Craig
Sherman

Bryan

Bryan

Bryan
King

Philip

Philip

Philip
Oettinger

Donna

Donna

Donna
Petkanics

Patrick

Patrick

Patrick
Schultheis

Chris

Chris

Chris
Fennell

See all ECP attorneys

recent news

we want to share
with you

Firm Advises Versant Ventures and NEA in Stablix’s $63 Million Series A Financing

Firm Advises Versant Ventures and NEA in Stablix’s $63 Million Series A Financing

Client Highlights06/08/21

Firm Advises Temasek on Helix’s $50 Million Series C Funding

Firm Advises Temasek on Helix’s $50 Million Series C Funding

06/06/21

Wilson Sonsini Advises Emboline on $55 Million Series D Funding to Launch Emboliner™

Wilson Sonsini Advises Emboline on $55 Million Series D Funding to Launch Emboliner™

06/02/21

Wilson Sonsini Advises RA Capital Management on Corporate, IP Matters Related to Forge Biologics' $120 Million Series B Financing

Wilson Sonsini Advises RA Capital Management on Corporate, IP Matters Related to Forge Biologics' $120 Million Series B Financing

05/11/21

events

we organize
for you

06/24/21

Medical Device Conference 2021

Wilson Sonsini’s 28th Annual Medical Device Conference will address issues of critical importance to today’s medical device companies

Register now

We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content. For more information or to opt-out, visit our privacy policy.